BBOT vs BTAI (BridgeBio Oncology Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Oct 4 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Before the Regular Session
Current time is 9:22 AM ET. The regular US trading session begins at 9:30 AM ET. Showing closing prices from the prior official trading session.
BBOT leads by +14.10% Alpha Spread Today
BBOT is trading at -7.46% while BTAI is at -21.56% .
Started At
Official opening auction price
Previous Close
Baseline for today's market open
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | BBOT | BTAI | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -7.46% | -21.56% | BBOT +14.10% |
| Net Dollar Move | $-0.29 | $-0.01 | BTAI higher move |
| Open Price | $3.88 | $0.05 | Gap: -0.26% vs 0.00% |
| Day High | $3.88 | $0.05 | Session peaks |
| Day Low | $3.58 | $0.03 | Session troughs |
| Intraday Spread | $0.30 | $0.02 | High/Low spread |
| Share Volume | 481.5K | 391.7K | BBOT more active |
| Est. Dollar Volume | $1.73M | $15.7K | BBOT higher liquidity |
Explore BBOT vs BTAI Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.